• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复静脉输注氯胺酮对难治性抑郁症患者面部表情识别能力的影响:初步报告

The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report.

作者信息

Shiroma Paulo R, Albott C Sophia, Johns Brian, Thuras Paul, Wels Joseph, Lim Kelvin O

机构信息

From the Minneapolis VA Medical Center, Mental Health Service Line, Minneapolis MN.

出版信息

J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):362-4. doi: 10.1176/appi.neuropsych.14100243. Epub 2015 Feb 6.

DOI:10.1176/appi.neuropsych.14100243
PMID:25658683
Abstract

In contrast to improvement in emotion recognition bias by traditional antidepressants, the authors report preliminary findings that changes in facial emotion recognition are not associated with response of depressive symptoms after repeated ketamine infusions or relapse during follow-up in treatment-resistant depression.

摘要

与传统抗抑郁药改善情绪识别偏差不同,作者报告了初步研究结果,即面部情绪识别的变化与难治性抑郁症患者反复输注氯胺酮后抑郁症状的反应或随访期间的复发无关。

相似文献

1
The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report.重复静脉输注氯胺酮对难治性抑郁症患者面部表情识别能力的影响:初步报告
J Neuropsychiatry Clin Neurosci. 2015 Fall;27(4):362-4. doi: 10.1176/appi.neuropsych.14100243. Epub 2015 Feb 6.
2
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.重复氯胺酮输注治疗共病创伤后应激障碍和治疗抵抗性抑郁症的疗效、安全性和持久性。
J Clin Psychiatry. 2018 May/Jun;79(3). doi: 10.4088/JCP.17m11634.
3
Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.氯胺酮对难治性重度抑郁症患者情绪感知神经反应的调节作用
Transl Psychiatry. 2015 Feb 17;5(2):e509. doi: 10.1038/tp.2015.10.
4
Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression: A Case Series.重复静脉注射氯胺酮治疗难治性老年抑郁症的效果:病例系列
J Clin Psychopharmacol. 2019 Mar/Apr;39(2):158-161. doi: 10.1097/JCP.0000000000001006.
5
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.单次、重复和维持性氯胺酮输注治疗难治性抑郁症的随机对照试验。
Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29.
6
Disentangling the association of depression on the anti-fatigue effects of ketamine.解析抑郁与氯胺酮抗疲劳作用的关系。
J Affect Disord. 2019 Feb 1;244:42-45. doi: 10.1016/j.jad.2018.10.089. Epub 2018 Oct 6.
7
[Ketamine--a new treatment option for therapy-resistant depression].[氯胺酮——难治性抑郁症的一种新治疗选择]
Fortschr Neurol Psychiatr. 2015 Feb;83(2):91-7. doi: 10.1055/s-0034-1398967. Epub 2015 Feb 27.
8
Ketamine for chronic depression: two cautionary tales.氯胺酮治疗慢性抑郁症:两个警示故事。
J Psychiatry Neurosci. 2019 Nov 1;44(6):384-385. doi: 10.1503/jpn.190073.
9
Ketamine safety and tolerability in clinical trials for treatment-resistant depression.氯胺酮治疗抵抗性抑郁症的临床试验中的安全性和耐受性。
J Clin Psychiatry. 2015 Mar;76(3):247-52. doi: 10.4088/JCP.13m08852.
10
Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.单剂量氯胺酮后每日服用D-环丝氨酸治疗难治性双相抑郁症。
J Clin Psychiatry. 2015 Jun;76(6):737-8. doi: 10.4088/JCP.14l09527.

引用本文的文献

1
Can ketamine and other glutamate receptor modulators be considered entactogens?氯胺酮及其他谷氨酸受体调节剂能否被视为致幻剂?
Psychiatry Res. 2025 Jul;349:116513. doi: 10.1016/j.psychres.2025.116513. Epub 2025 Apr 25.
2
Personalized use of ketamine and esketamine for treatment-resistant depression.个体化使用氯胺酮和艾司氯胺酮治疗难治性抑郁症。
Transl Psychiatry. 2024 Nov 29;14(1):481. doi: 10.1038/s41398-024-03180-8.
3
Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study.
皮下注射氯胺酮治疗姑息治疗患者重度抑郁症(SKIPMDD)的 II 期单臂开放标签可行性研究。
PLoS One. 2023 Nov 14;18(11):e0290876. doi: 10.1371/journal.pone.0290876. eCollection 2023.
4
Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study).SKIPMDD 研究方案:晚期生命有限的患有重度抑郁症的姑息治疗患者皮下注射氯胺酮治疗(二期试点可行性研究)。
BMJ Open. 2021 Jun 28;11(6):e052312. doi: 10.1136/bmjopen-2021-052312.
5
Ketamine: A Review for Clinicians.氯胺酮:临床医生综述
Focus (Am Psychiatr Publ). 2018 Jul;16(3):243-250. doi: 10.1176/appi.focus.20180012. Epub 2018 Jul 16.